You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Which of the following is a lipoxygenase inhibitor: March 2012 and explain in detail?
Ans: C i.e. Zileuton Drugs and mechanism of action Montelukast competitively antagonize cysLT1 receptor mediated bronchoconstriction, increased vascular permeability and recruitment of eosinophils. Thromboxane acts by binding to any of the thromboxane receptors, G protein coupled receptors coupled to G-protein Gq. Zileuton is a 5 lipo-oxygenase inhibitor, blocks LT C4/ D4 as well as LTB4 synthesis. Sodium cromoglycate inhibits degranulation of mast cells. The basis of this effect is not well understood, but may involve a delayed chloride channel in the membrane of these cells.